A comparison of succinyladenylate lyase activity and serum sialic acid as markers of malignancy

Donald O. Mack, Ellen M. Lewis, E.Marie Butler, William H. Archer, Larry D. Smith
{"title":"A comparison of succinyladenylate lyase activity and serum sialic acid as markers of malignancy","authors":"Donald O. Mack,&nbsp;Ellen M. Lewis,&nbsp;E.Marie Butler,&nbsp;William H. Archer,&nbsp;Larry D. Smith","doi":"10.1016/0006-2944(85)90095-X","DOIUrl":null,"url":null,"abstract":"<div><p>A comparison was made of succinyladenylate lyase (SAMP lyase), total serum sialic (TSA), and lipid soluble serum sialic acid (LSA) as early markers of malignancy in three experimentally induced rat tumor models. Elevation of SAMP lyase in 3′-methyl-dimethylaminoazobenzene-induced hepatic tumors at 2 weeks corresponded with microscopic detection of preneoplastic lesions with elevation of LSA occurring 2 weeks later. Elevation of breast SAMP lyase concurred with macroscopic presence of dimethylbenzanthracene involved breast tumors with elevation of LSA occurring 12 weeks later. Neither colon SAMP lyase nor LSA increased in rats bearing colon tumors induced by dimethylhydrazine. The determination of TSA was not a reliable indicator of tumor presence for the three types of tumors investigated. Both SAMP lyase and LSA are very good early indicators of hepatic tumor with SAMP lyase an earlier indicator of breast tumor than LSA.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 3","pages":"Pages 327-334"},"PeriodicalIF":0.0000,"publicationDate":"1985-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90095-X","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/000629448590095X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

A comparison was made of succinyladenylate lyase (SAMP lyase), total serum sialic (TSA), and lipid soluble serum sialic acid (LSA) as early markers of malignancy in three experimentally induced rat tumor models. Elevation of SAMP lyase in 3′-methyl-dimethylaminoazobenzene-induced hepatic tumors at 2 weeks corresponded with microscopic detection of preneoplastic lesions with elevation of LSA occurring 2 weeks later. Elevation of breast SAMP lyase concurred with macroscopic presence of dimethylbenzanthracene involved breast tumors with elevation of LSA occurring 12 weeks later. Neither colon SAMP lyase nor LSA increased in rats bearing colon tumors induced by dimethylhydrazine. The determination of TSA was not a reliable indicator of tumor presence for the three types of tumors investigated. Both SAMP lyase and LSA are very good early indicators of hepatic tumor with SAMP lyase an earlier indicator of breast tumor than LSA.

琥珀酰腺酸裂解酶活性与血清唾液酸作为恶性肿瘤标志物的比较
比较了三种实验性大鼠肿瘤模型中琥珀酰腺酸裂解酶(SAMP裂解酶)、血清总唾液酸(TSA)和脂溶性血清唾液酸(LSA)作为恶性肿瘤早期标志物的作用。3 ' -甲基-二甲氨基偶氮苯诱导的肝脏肿瘤在2周时SAMP裂解酶升高,与2周后出现LSA升高的肿瘤前病变的显微镜检测相对应。乳腺SAMP裂解酶升高与肉眼可见的二甲苯并蒽累及乳腺肿瘤同时发生,并在12周后出现LSA升高。二甲肼诱导的结肠肿瘤大鼠结肠SAMP裂解酶和LSA均未升高。对于所研究的三种类型的肿瘤,TSA的测定不是肿瘤存在的可靠指标。SAMP裂解酶和LSA都是肝脏肿瘤很好的早期指标,其中SAMP裂解酶比LSA更早诊断乳腺肿瘤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信